Safety: Clinical Trials

6 trials for Safety, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 6

Follow Safety: new trials by email Literature Review of Safety trials Research Report on Safety

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study
mRNA COVID-19 vaccine, IIV4 (quadrivalent inactivated influenza vaccine) - Birth Outcomes, Safety
Phase 4CompletedDuke University982024-09-122026-10-07
Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines
bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine, quadrivalent influenza vaccine - Immune Response, Safety
Phase 4CompletedCatholic Kwandong University1542022-10-122024-03-26
Safety of RIV4 Versus IIV4 in Pregnant Women
Quadrivalent Recombinant Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccine - Safety, Adverse Event Following Immunisation
Phase 4CompletedDuke University3842019-09-052023-01-11
Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML
Gemtuzumab Ozogamicin - ECG, Pharmacokinetics
Phase 4CompletedPfizer512019-07-032022-03-25
Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.
13-valent pneumococcal conjugate vaccine - 13-valent Pneumococcal Vaccine, Premature Birth
Phase 4CompletedPfizer2002010-10-012017-05-11
FDA Phase IV - Commitment - Retinal Function Study
Sildenafil, Placebo, Vardenafil (Levitra, BAY38-9456) - Safety
Phase 4CompletedBayer632005-02-012015-03-19

Narrower conditions

Influenza, Human (1)  ·  Premature Birth (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (1)  ·  Infections (1)  ·  Obstetric Labor Complications (1)  ·  Obstetric Labor, Premature (1)  ·  Orthomyxoviridae Infections (1)  ·  Pregnancy Complications (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Urogenital Diseases (1)  ·  Virus Diseases (1)

Interventions

Influenza Vaccines (3)  ·  CVnCoV COVID-19 vaccine (1)  ·  FluLaval (1)  ·  Gemtuzumab (1)  ·  Sildenafil Citrate (1)  ·  Vardenafil Dihydrochloride (1)

Sponsors

Duke University (2)  ·  Pfizer (2)  ·  Bayer (1)  ·  Catholic Kwandong University (1)

Countries

United States (3)  ·  Poland (2)  ·  Spain (2)  ·  Canada (1)  ·  Hungary (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Elizabeth Barnett, MD (1)  ·  Elizabeth Schlaudecker, MD, MPH (1)  ·  Geeta K Swamy, MD (1)  ·  Geeta Swamy, MD (1)  ·  Karen R Broder, MD (1)  ·  Matthew Crist, MD (1)  ·  Matthew Zuber, MD (1)  ·  Min Joo Choi, Doctor (1)  ·  Satoshi Kamidani, MD, PhD (1)

Results publications

PMID 25780077, PMID 27902652, PMID 36892676

NIH funding

2009 (1), 2018 (1)